Print
INNOVATION:
Obama Administration Offers $1 Billion for Healthcare InnovationHHS awards designed to transform delivery and payment systems.
U.S. Secretary of Health and Human Services Kathleen Sebelius announced that nearly $1 billion will be made available in the second round of Health Care Innovation Awards for projects that have a “high likelihood” of cutting cost while delivering better outcomes. Read More
Court Rulings
Supreme Court Rules Unanimously in Favor of MonsantoJudges find Indiana farmer violated company’s patent when he reproduced its biotech seed. Read More.Regulatory
U.S. Trade Representative Puts Focus on Indian IP IssuesFollowing a challenging year for Big Pharma, U.S. urges India to protect innovators. Read More.Generics and Biosimilars
Florida Eases the Way for BiosimilarsState-by-state, legislators are considering balance between ease of access and safety. Read More.Healthcare Reform
What Transparency Means for HealthcarePodcast: May 13, 2013 Read More.Litigation
European Court Enjoins EMA from Releasing AbbVie, InterMune DataDecision heats up the battle over pharmaceutical data transparency. Read More.Legislation
Bill Would Require Labels for Genetically Engineered FoodsFirst such legislation introduced in Senate in more than a dozen years. Read More.Drug Prices
Doctors Worldwide Call for Lower Cancer Drug PricesCosts topping $100,000 for chronic myeloid leukemia called unsustainable, profiteering charged. Read More.Regulatory
FDA Won’t Approve Generic OxycontinDecision signals agency’s intention to insist on abuse-resistant forms of drug. Read More.Patents
Supreme Court Hears Oral Arguments in Myriad caseJustices search for balance. Read More.Legislation
Obama Budget Raises Ire of PhRMA, BIOTrade groups blast proposal as harmful to innovation, job growth, and patients. Read More.Capital Markets
The JOBS Act One Year LaterPodcast: April 8, 2013 Read More.Patents
U.S. Trade Representative Reviewing India’s Denial of Glivec PatentIndustry groups say it will hinder innovation and investment in the country. Read More.Commentary
Gleevec Ruling Is a Blow to Global Public HealthDecision is economically-driven, short-term, with potentially deadly unintended consequences. Read More.Regulatory
SCOTUS Weighs Pay-for-Delay Podcast: April 1, 2013 Read More.Biodefense
Expanding Research on Highly Toxic Agents Concerns Government Accounting OfficeNo consensus exists on which federal agency, if any, should regulate research labs possessing dangerous pathogens. Read More.
.gif)
.png){kind=small} |
 |